Skip to content

US · ARDT · MEDICAL - CARE FACILITIES

Ardent Health Inc. (ARDT) intrinsic value and stock valuation

$15.08as of 2026-11-21 · Mkt cap 1.6B

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Ardent Health Inc. DCF and intrinsic value

InvestorsCraft values ARDT with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from ARDT’s statements →

Ardent Health Inc. Graham Number

Graham Number: $16.12d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities Brentwood, TN 37027 ardenthealth.com

How the business is doing

Fiscal 2015–2025, USD

Revenue
$6.32B+8.7% 5y CAGRd
20152025
Net income
$135.8M
20152025
Free cash flow
$258.6M
20152025
Total equity
$1.68B+17.3% 5y CAGRd
20162025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2015–2025, USD
20252024202320222021
Revenue$6.32B$5.97B$5.41B$5.13B$4.87B
Operating income$325.6M$405.8M$229.5M$217M$436.6M
Net income$135.8M$210.3M$50.3M$188.9M$154.3M
EPSd$960.1K$1.58M$351K$1.32M$1.08M
Operating cash flow$470.5M$315M$221.7M-$-38.36M$146.9M
Capital expenditure-$-211.9M-$-187.51M-$-137.41M-$-151.11M-$-139M
Free cash flow$258.6M$127.5M$84.3M-$-189.47M$7.91M
Total assets$5.29B$4.96B$5.1B$4.86B—
Total debt$2.26B$2.28B$2.4B$2.39B—
Net debt$1.55B$1.73B$1.96B$1.93B—
Total equity$1.68B$1.52B$1.08B$1.05B—
Cash and short-term investments$709.6M$556.8M$437.6M$456.1M—
Income statement
20252024202320222021
Revenue$6.32B$5.97B$5.41B$5.13B$4.87B
Cost of revenue$155.7M$1.03B$140.8M$955.2M$927.3M
Gross profit$6.17B$4.93B$5.27B$4.17B$3.94B
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$1.19B$3.88B$3.62B$3.37B$3.13B
Other expenses$4.65B$642.5M$1.42B$585.8M$374.2M
Operating expenses$5.84B$4.53B$5.04B$3.96B$3.51B
Cost and expenses$6B$5.56B$5.18B$4.91B$4.43B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$55.2M$65.6M$65.4M$82.1M$93.8M
Depreciation and amortization$155.7M$146.3M$140.8M$138.2M$137.2M
Ebitda$497.3M$574.9M$350M$531.7M$526.9M
Operating income$325.6M$405.8M$229.5M$217M$436.6M
Total other income/expenses, net-$-39.23M-$-42.7M-$-77.89M$94.5M-$-140.68M
Income before tax$286.4M$363.1M$151.6M$311.5M$295.9M
Income tax expense$56.2M$63.4M$22.6M$46.1M$51.3M
Net income$135.8M$210.3M$50.3M$188.9M$154.3M
Weighted average shares outstanding$140.8M$132.4M$143.3M$143.3M$143.3M
Weighted average diluted shares outstanding$141.5M$132.8M$143.3M$143.3M$143.3M
Balance sheet
20252024202320222018
Cash and short-term investments$709.6M$556.8M$437.6M$456.1M$59.7M
Net receivables$686.1M$743M$785.8M$612M$529.1M
Inventory$118.6M$115.1M$105.5M$107.2M$84.8M
Total current assets$2.06B$1.83B$1.62B$1.41B$860.4M
Property, plant and equipment, net$2.14B$2.04B$2.01B$1.99B$839.9M
Goodwill and intangible assets$968.8M$929M$921.6M$921.6M$899.9M
Long-term investments$0.00$11.5M$17.8M$29.4M$0.00
Total non-current assets$3.23B$3.12B$3.48B$3.45B$1.89B
Total assets$5.29B$4.96B$5.1B$4.86B$2.75B
Accounts payable$457.9M$401.3M$474.5M$320.8M$230.4M
Short-term debt$23.4M$55.6M$61M$58.4M$8.96M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$1.05B$945.4M$994.1M$808.6M$624.8M
Long-term debt$2.24B$2.23B$2.34B$2.33B$1.25B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$2.56B$2.49B$3.03B$3B$1.41B
Capital lease obligations$1.17B$1.2B$1.18B$1.18B$0.00
Total liabilities$3.61B$3.43B$4.02B$3.81B$2.03B
Common stock$1.43M$1.43M$496.9M$511M$504.7M
Retained earnings$501.6M$365.8M$155.5M$101.6M-$-167.16M
Accumulated other comprehensive income (loss)-$-3.61M$9.74M$18.6M$26.5M-$-5.89M
Total equity$1.68B$1.52B$1.08B$1.05B$711.8M
Total investments$0.00$11.5M$17.8M$29.4M$77.8M
Total debt$2.26B$2.28B$2.4B$2.39B$1.26B
Net debt$1.55B$1.73B$1.96B$1.93B$1.2B
Cash flow statement
20252024202320222021
Net income$230.1M$299.7M$129M$265.4M$244.6M
Depreciation and amortization$155.7M$146.3M$140.8M$138.2M$137.2M
Stock-based compensation$39.3M$18M$900K$610K$550K
Change in working capital-$-3.34M-$-181.75M-$-56.31M-$-9.74M-$-89.55M
Accounts receivable$59.2M$40M-$-181.1M-$-17.18M-$-96.47M
Inventory-$-3.15M-$-9.41M$1.67M$4.67M-$-5.73M
Accounts payable$62.1M-$-103.86M$136.8M$14.4M$109.4M
Net cash provided by operating activities$470.5M$315M$221.7M-$-38.36M$146.9M
Investments in property, plant and equipment-$-211.9M-$-187.51M-$-137.41M-$-151.11M-$-139M
Acquisitions, net-$-2.5M-$-31.25M$0.00$206.4M-$-2.28M
Net cash used for investing activities-$-214.23M-$-220.46M-$-137.98M$46.6M-$-136.26M
Common stock issued$0.00$208.7M$0.00$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00-$-174.81M-$-62.13M
Net cash used for financing activities-$-103.47M$24.6M-$-102.26M-$-270.33M-$-283.91M
Net change in cash$152.8M$119.2M-$-18.55M-$-262.11M-$-273.26M
Cash at end of period$709.6M$556.8M$437.6M$456.1M$718.2M
Operating cash flow$470.5M$315M$221.7M-$-38.36M$146.9M
Capital expenditure-$-211.9M-$-187.51M-$-137.41M-$-151.11M-$-139M
Free cash flow$258.6M$127.5M$84.3M-$-189.47M$7.91M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Ardent Health Inc.

        Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers. The company operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. Ardent Health, Inc. was formerly known as Ardent Health Partners, Inc. and changed its name to Ardent Health, Inc. in June 2025. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

        CEO
        Dave Caspers
        Employees
        25.2K
        Beta
        0.75

        Explore

        Frequently asked questions

        What is the intrinsic value of Ardent Health Inc. (ARDT)?

        Ardent Health Inc. (ARDT) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is ARDT undervalued?

        ARDT trades at a price of $15.08 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.